Female Sexual Dysfunction in Renal Failure

NCT ID: NCT03172637

Last Updated: 2017-06-01

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2017-07-01
• Study Completion Date: 2018-12-31

Brief Summary

A myriad of sexual problems affect men and women with chronic kidney disease (CKD), including decreased libido, erectile dysfunction, dysmenorrhea, and infertility. Menstrual abnormalities are common in CKD and many women are an-ovulatory .

Causes of sexual dysfunction in CKD include hormonal alterations along with vascular, neurologic, psychogenic, and other factors, such as medications, contribute to the development of sexual dysfunction . Sexual dysfunction in females is mainly due to hormonal factors and manifests mainly as menstrual irregularities, amenorrhea, lack of vaginal lubrication, and failure to conceive.

Detailed Description

Hormonal changes in chronic kidney disease are seen in prolactine, gonadotropins, and gonadal hormones. In women with CKD, elevated levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are common. These hormonal changes are detected in the early stages of kidney disease and progressively worsen as kidney disease progresse .

. Women with chronic renal failure commonly have elevated circulating prolactin levels. As in men with chronic renal failure, the hypersecretion of prolactin in this setting appears to be autonomous, as it is resistant to maneuvers designed to stimulate or inhibit its release.

It has been suggested that the elevated prolactin levels may impair hypothalamic-pituitary function and contribute to sexual dysfunction and galactorrhea in these patients. However, uremic women treated with bromocryptine rarely resume normal menses and continue to complain of galactorrhea (if present), despite normalization of the plasma prolactin concentration. Thus, factors other than hyperprolactinemia must be important in this setting .

Conditions

Evaluations of Sexual Dysfunction of Female in Chronic Renal Failure

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Group A

50 female end stage renal disease patients

No interventions assigned to this group

Group B

50 normal female patients

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• -Female patients with chronic renal failure (eGFR <15 ml/min/1.7m2 ) on dialysis or not.
• Age from 18 to 45 years old.
• Married.
• Sexually active during the last 6 monthes.

Exclusion Criteria

• Pregnant women.
• Other medical diseases ( diabetes mellitus ,cardiac disorders ,neurological disorders and other systematic diseases).
• Taking medications affect sexuality function e.g. antidepressant drugs.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Esraa Ahmed Mohamed

OTHER

Sponsor Role: lead

Responsible Party

Esraa Ahmed Mohamed

GP

Responsibility Role: SPONSOR_INVESTIGATOR

Other Identifiers

FSDRF

Identifier Type: -

Identifier Source: org_study_id